Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor belonging to the xanthine derivative class, distinguished from shorter-acting compounds by its exceptionally prolonged plasma half-life and smooth-muscle relaxation profile.
Mechanism & Pharmacology of Tadalafil
Tadalafil selectively inhibits phosphodiesterase type 5, the enzyme responsible for degrading cyclic guanosine monophosphate (cGMP) in smooth muscle tissue. When PDE5 is inhibited, cGMP concentrations rise within vascular smooth muscle cells, activating protein kinase G and triggering a cascade that results in myosin light-chain dephosphorylation and pronounced vasodilation. This mechanism operates downstream of nitric oxide (NO) signalling: nitric oxide activates soluble guanylate cyclase, which converts GTP to cGMP, and tadalafil prolongs that signal by preventing cGMP breakdown.
What separates tadalafil from other PDE5 inhibitors is its pharmacokinetic profile. The compound reaches peak plasma concentration (Cmax) approximately 2 hours after oral administration, yet its terminal half-life extends to roughly 17.5 hours — more than three times longer than sildenafil's 4-hour half-life. This gives tadalafil an effective action window of up to 36 hours, earning it the informal designation "the weekend compound" in clinical literature. Oral bioavailability is not significantly affected by food intake or moderate alcohol consumption, a practical advantage noted in formal pharmacokinetic studies. Protein binding is approximately 94%, with hepatic metabolism via CYP3A4 producing an inactive catechol metabolite that is excreted primarily in faeces.
At the molecular level, tadalafil binds the catalytic domain of PDE5 with an IC₅₀ of approximately 5 nM, demonstrating roughly 10,000-fold selectivity for PDE5 over PDE3 (the cardiac isoform), which underpins its comparatively favourable cardiovascular tolerability profile at therapeutic doses. Selectivity over PDE6 — the retinal isoform — is also markedly higher than that of sildenafil, which is reflected in the lower incidence of visual disturbances reported with tadalafil use.
Beyond vascular smooth muscle, tadalafil also relaxes the smooth muscle of the lower urinary tract and prostate, a pharmacological action that has been formally recognised in clinical guidelines for managing benign prostatic hyperplasia. This secondary mechanism gives tadalafil a dual-action utility that distinguishes it from single-indication PDE5 inhibitors.
Application Context & User Groups
Within bodybuilding and performance communities, tadalafil is used for its haemodynamic effects rather than any direct anabolic action. By promoting vasodilation and increasing blood flow through nitric oxide-pathway potentiation, tadalafil is perceived to support nutrient delivery to working muscle tissue, enhance the subjective "pump" during resistance training, and improve intra-workout endurance — particularly in high-volume, hypertrophy-focused programmes.
Athletes using androgenic-anabolic steroids (AAS) sometimes incorporate tadalafil as a support compound. Certain anabolic steroids are associated with increased blood pressure and reduced arterial compliance over extended cycles; tadalafil's vasodilatory properties are used as a haemodynamic countermeasure in such contexts. This is an empirical, community-derived practice rather than one supported by controlled clinical trials in the performance setting, and users are advised to monitor blood pressure readings regularly.
Tadalafil is also well established among older male athletes and recreational lifters who experience exercise-induced reductions in blood flow or early-stage vascular ageing. Research published in peer-reviewed cardiovascular journals has shown that chronic low-dose tadalafil (2.5–5 mg daily) improves flow-mediated dilation — a validated surrogate marker of endothelial function — suggesting genuine vascular benefits beyond acute haemodynamics.
A further user group comprises individuals managing erection-related side effects secondary to anabolic steroid use, where suppression of endogenous testosterone and alteration of nitric oxide synthase activity can impair vascular response. Tadalafil addresses the downstream vascular deficit directly, operating independently of hormonal status, making it effective in this context even during active hormonal suppression.
It is worth noting that tadalafil is not a stimulant, does not affect the androgen receptor, and produces no direct anabolic signal. Its role in bodybuilding contexts is purely cardiovascular and haemodynamic. Users should be aware that co-administration with nitrate-containing compounds is contraindicated due to the risk of severe hypotension, and caution is warranted alongside other potent vasodilators.
Range & Selection by Concentration and Pack Size
The tadalafil range available in this category spans two principal concentration tiers — 20 mg and 60 mg — across tablet and oral jelly delivery formats, allowing users to match dose, pack size, and administration preference to their specific protocol.
Apcalis Oral Jelly 20mg by Ajanta Pharma is the category's sole gel-sachet format, supplied in packs of 7 sachets at 20 mg per sachet. This format is suited to users who prefer faster mucosal absorption and dislike swallowing tablets; the jelly formulation dissolves rapidly in the oral cavity and is popular among those who use tadalafil on an as-needed basis rather than as a daily sub-therapeutic dose. The 7-sachet pack is ideal for weekly protocols or trial periods.
Cialis 20mg by Lilly remains the reference-brand product in the 20 mg tablet tier, available in a 4-tablet pack — the smallest unit count in the range. Lilly's product carries the original pharmaceutical-grade formulation and is the compound against which all generic variants are benchmarked. The 4-tablet pack suits users who prefer confirmed reference-brand quality for occasional use or who are evaluating tadalafil's response profile before committing to larger quantities.
Vidalista 20 by Centurion Laboratories provides the same 20 mg tablet dose in packs of 100 tablets, making it the practical choice for those running extended daily or semi-daily low-dose protocols (2.5–10 mg/day is achievable by splitting tablets) or for high-frequency users who benefit from bulk purchasing. Centurion Laboratories is one of the most established Indian generic pharmaceutical manufacturers, with consistent third-party batch testing reported across the bodybuilding community.
At the 60 mg tier, two products compete for users seeking higher single-dose potency. Vidalista 60 by Centurion Laboratories and Vikalis VX 60 by Shree Venkatesh both supply 60 mg per tablet in 100-tablet packs. This concentration tier is reserved for experienced users who have established tolerability at 20 mg and require a stronger haemodynamic response, or for those using tadalafil on an infrequent schedule where a single high-dose tablet suffices for an extended window. The 60 mg dose should not be the entry point for new users. Between the two 60 mg options, Vidalista 60 benefits from Centurion's wider manufacturing reputation, while Vikalis VX 60 by Shree Venkatesh offers a credible alternative from another established Indian pharmaceutical house with documented export pedigree.
Users new to tadalafil are recommended to begin with the 20 mg tier — either the Apcalis jelly for flexible dosing or Vidalista 20 for cost-effective bulk supply — before considering the 60 mg options.
Frequently Asked Questions
How long does tadalafil remain active in the body compared to other PDE5 inhibitors?
Tadalafil has a terminal half-life of approximately 17.5 hours, giving it an effective action window of up to 36 hours — significantly longer than sildenafil (around 4 hours) or vardenafil (around 4–5 hours). This extended duration makes it particularly suitable for daily low-dose protocols or situations where precise timing is impractical.
What is the difference between the 20mg and 60mg tadalafil tablets available in this range?
The 20 mg dose is the standard clinical benchmark and the appropriate starting point for most users. The 60 mg tablets — such as Vidalista 60 and Vikalis VX 60 — deliver three times the standard dose in a single tablet, providing a stronger and more sustained haemodynamic effect. The 60 mg tier is intended for experienced users with confirmed tolerability at lower doses, not first-time users.
Can tadalafil be used daily at a low dose rather than as a one-off tablet?
Yes. Tadalafil is formally approved at 2.5–5 mg daily for continuous use in clinical settings. Within bodybuilding contexts, users sometimes split 20 mg tablets to achieve sub-therapeutic daily doses, aiming for consistent baseline vasodilation and improved endothelial function over time. The 100-tablet packs from Centurion Laboratories make this approach economically practical.
Pharma Grade
